Inhibition of p53 deSUMOylation exacerbates puromycin aminonucleoside-induced apoptosis in podocytes.
Inhibition of p53 deSUMOylation exacerbates puromycin aminonucleoside-induced apoptosis in podocytes.
复制标题
DOI:
10.3390/ijms151121314
复制
发表时间:
2014-11-18
影响因子:
5.6
通讯作者:
Lin H
中科院分区:
文献类型:
--
作者:
Wang L;Zhu J;Fang M;Zhang T;Xie H;Wang N;Shen N;Guo H;Fu B;Lin H
Apoptosis is a major cause of reduced podocyte numbers, which leads to proteinuria and/or glomerulosclerosis. Emerging evidence has indicated that deSUMOylation, a dynamic post-translational modification that reverses SUMOylation, is involved in the apoptosis of Burkitt’s lymphoma cells and cardiomyocytes; however, the impact of deSUMOylation on podocyte apoptosis remains unexplored. The p53 protein plays a major role in the pathogenesis of podocyte apoptosis, and p53 can be SUMOylated. Therefore, in the present study, we evaluated the effect of p53 deSUMOylation, which is regulated by sentrin/SUMO-specific protease 1 (SENP1), on podocyte apoptosis. Our results showed that SENP1 deficiency significantly increases puromycin aminonucleoside (PAN)-induced podocyte apoptosis. Moreover, SENP1 knockdown results in the accumulation of SUMOylated p53 protein and the increased expression of the p53 target pro-apoptotic genes, BAX, Noxa and PUMA, in podocytes during PAN stimulation. Thus, SENP1 may be essential for preventing podocyte apoptosis, at least partly through regulating the functions of p53 protein via deSUMOylation. The regulation of deSUMOylation may provide a novel strategy for the treatment of glomerular disorders that involve podocyte apoptosis.
登录
查看更多内容
影响因子:
20.1
作者:
Heo KS;Chang E;Le NT;Cushman H;Yeh ET;Fujiwara K;Abe J
通讯作者:
Abe J
影响因子:
12.4
作者:
通讯作者:
--
影响因子:
11.4
作者:
Chao, Connie;Herr, Deron;Xu, Yang
通讯作者:
Xu, Yang
影响因子:
21.3
作者:
Kim, Jung Hwa;Choi, Hee June;Baek, Sung Hee
通讯作者:
Baek, Sung Hee
影响因子:
11.4
作者:
Gostissa, M;Hengstermann, A;Del Sal, G
通讯作者:
Del Sal, G